Report : Asia Pacific Infectious Disease Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Kits & Reagents, Instruments, and Software & Services), Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, Clinical Microbiology, and Others), Testing Type (Laboratory Testing and Point of Care Testing), Disease Indication (HIV, Hepatitis, Healthcare-Associated Infections, Human Papillomavirus, Tuberculosis, Influenza, and Others), and End User (Hospitals and Clinics, Pathology/Diagnostic Laboratories, Research Institutes, Home Care Settings, and Others)
Immunodiagnostics Segment to Dominate APAC Infectious Disease Diagnostics Market During 2021–2028
According to a new market research study on “APAC Infectious Disease Diagnostics Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Technology, Testing Type, Disease Indication and End User” is expected to reach US$ 8,810.33 million by 2028 from US$ 5,373.58 million in 2021. The market is estimated to grow at a CAGR of 7.3% from 2021 to 2028. The report provides trends prevailing in the APAC infectious disease diagnostics market along with the drivers and restraints pertaining to the market growth. Growing opportunities in developing countries is the major factor driving the growth of the APAC infectious disease diagnostics market. However, inadequate reimbursement scenario may hamper the growth of the market hinders the growth of APAC infectious disease diagnostics market.
The APAC infectious disease diagnostics market is analyzed based on product, technology, testing type, disease indication and end user, and country. Based on product, the APAC infectious disease diagnostics market, has been segmented into kits and reagents, instruments, and software and services. The kits and reagents segment dominated the market in 2020 and software and services segment is expected to be fastest growing during forecast period. Based on technology, the market is segmented into immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. The next generation sequencing segment dominated the market in 2020 and is expected to be fastest growing during forecast period. Based on testing type, the market is segmented into laboratory testing and point of care testing. The laboratory testing segment dominated the market in 2020 and point of care testing segment is expected to be fastest growing during forecast period. Based on disease indication, the market is segmented into HIV, Hepatitis, Healthcare Associated Infections, Human Papillomavirus, Tuberculosis, Influenza, and Others. The hepatitis segment dominated the market in 2020 and healthcare- associated infections (HAIs) segment is expected to be fastest growing during forecast period. Based on end user, the APAC infectious disease diagnostics market, has been segmented into hospitals and clinics, pathology/ diagnostic laboratories, research institutes, home care settings, and others. The pathology/ diagnostic laboratories segment dominated the market in 2020 and home care settings segment is expected to be fastest growing during forecast period. Based on country, the APAC infectious disease diagnostics market is segmented into China, Japan, India, Australia, South Korea, and Rest of APAC.
Abbott; AccuBioTech Co., Ltd.; ACON Laboratories, Inc.; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Cardinal Health Inc; Danaher; F. HOFFMANN-LA ROCHE LTD.; and Trinity Biotechare among the leading companies in the APAC infectious disease diagnostics market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, CerTest Biotec, along with BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2 Real Time PCR Detection Kit adapted for the BD MAX System has been CE marked to the IVD Directive (98/79/CE). The molecular test for detection of COVID-19 is available to clinical laboratories in countries recognizing the CE mark.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id: sales@businessmarketinsights.com